alpha-(n6-adenyl)styrene oxide has been researched along with ergocornine in 1 studies
Studies (alpha-(n6-adenyl)styrene oxide) | Trials (alpha-(n6-adenyl)styrene oxide) | Recent Studies (post-2010) (alpha-(n6-adenyl)styrene oxide) | Studies (ergocornine) | Trials (ergocornine) | Recent Studies (post-2010) (ergocornine) |
---|---|---|---|---|---|
8 | 0 | 2 | 48 | 0 | 9 |
Protein | Taxonomy | alpha-(n6-adenyl)styrene oxide (IC50) | ergocornine (IC50) |
---|---|---|---|
5-hydroxytryptamine receptor 4 | Cavia porcellus (domestic guinea pig) | 0.104 | |
Cytochrome P450 3A4 | Homo sapiens (human) | 0.5 | |
Alpha-2A adrenergic receptor | Homo sapiens (human) | 0.0063 | |
D(2) dopamine receptor | Homo sapiens (human) | 0.005 | |
Alpha-2B adrenergic receptor | Homo sapiens (human) | 0.0031 | |
Alpha-2C adrenergic receptor | Homo sapiens (human) | 0.017 | |
5-hydroxytryptamine receptor 1A | Rattus norvegicus (Norway rat) | 0.0031 | |
D(1A) dopamine receptor | Homo sapiens (human) | 0.294 | |
Thromboxane-A synthase | Homo sapiens (human) | 1.993 | |
Alpha-1D adrenergic receptor | Homo sapiens (human) | 0.018 | |
5-hydroxytryptamine receptor 2A | Homo sapiens (human) | 0.028 | |
5-hydroxytryptamine receptor 2C | Homo sapiens (human) | 0.104 | |
5-hydroxytryptamine receptor 1B | Rattus norvegicus (Norway rat) | 0.0031 | |
D(3) dopamine receptor | Homo sapiens (human) | 0.0029 | |
5-hydroxytryptamine receptor 2B | Homo sapiens (human) | 0.011 | |
5-hydroxytryptamine receptor 6 | Homo sapiens (human) | 0.015 | |
BZLF2 | Human herpesvirus 4 type 2 (Epstein-Barr virus type 2) | 3.64 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Butkiewicz, M; Lowe, EW; Meiler, J; Mendenhall, JL; Mueller, R; Teixeira, PL; Weaver, CD | 1 |
1 other study(ies) available for alpha-(n6-adenyl)styrene oxide and ergocornine
Article | Year |
---|---|
Benchmarking ligand-based virtual High-Throughput Screening with the PubChem database.
Topics: Algorithms; Animals; Area Under Curve; Computer Simulation; Databases, Chemical; Decision Trees; Drug Discovery; High-Throughput Screening Assays; Humans; Inhibitory Concentration 50; Ligands; Models, Chemical; Neural Networks, Computer; Quality Improvement; Quantitative Structure-Activity Relationship; ROC Curve; Support Vector Machine | 2013 |